Dr. Blair Ardman, MD

Dr. Ardman practices at Lowell General Hospital in Lowell, Massachusetts, part of Tufts Medicine.

Dr. Ardman's NPI, 1578510160, was assigned on May 28, 2006. Dr. Ardman graduated from Sidney Kimmel Medical College in 1977. Dr. Ardman's Massachusetts license number on file is 47026.

Dr. Ardman's primary practice is Lowell General Hospital, at 295 Varnum Avenue, Lowell, MA 01854 in Middlesex County. The practice phone is (978) 937-6000.

Dr. Ardman's primary practice is Lowell General Hospital in Lowell, Massachusetts, part of Tufts Medicine. The medical group on file is Lowell General Hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ardman practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Ardman's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Ardman is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Ardman's licenses on file in 2 states: Massachusetts and Pennsylvania.

Dmand AI lists lung cancer, lymphoma and multiple myeloma among the conditions Dr. Ardman treats.

CMS data shows 739 Medicare services from Dr. Ardman across 6 procedure codes in 2024, for 242 Medicare patients. Medicare paid $47,600 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 242 Medicare patients who saw Dr. Ardman in 2024. The largest group is 75 to 84, with 106 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ardman's median patient age at 67, with 52% women.

In 2017, Dr. Ardman wrote 13 Medicare Part D claims. They cover 1 drug, with $5,132 in total drug cost. In 2016, CMS named 22 claims across 2 drugs.

Dr. Ardman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 22 papers to Dr. Ardman, published from 2021 to 2024. 2021 was the busiest year, with 2. The most frequent topics are T-Lymphocytes, Antigens, CD and Leukosialin. Dr. Ardman has published most often in J Immunol. Dr. Ardman's most frequent co-authors are Vandana Gupta Abramson, MD, Ron Bose, MD and Kit L. Cheng, MD.

Dmand AI links Dr. Ardman to 20 clinical trials, 12 of them phase 3 studies. 11 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Carcinoma, Non-Small-Cell Lung. National Cancer Institute (NCI) sponsors the most, 6.

CMS Open Payments shows 51 general payments to Dr. Ardman from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 62% of the total. Alexion Pharmaceuticals, Inc. paid the most, $731.

Dmand AI lists 3 awards for Dr. Ardman, most recently Regional Top Doctor in 2014.

Dr. Ardman graduated from Sidney Kimmel Medical College in 1977.

Dr. Ardman is in network with 13 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.